Skip to main content
. 2022 Jul 27;6(4):284–289. doi: 10.1177/24741264221099429

Figure 1.

Figure 1.

Correlations between changes in BCVA and changes in CST from baseline in patients treated with IAI 2q4 at (A) week 12, (B) week 52, and (C) week 100. Solid lines indicate the correlation line, and dashed lines indicate the 95% CI. Abbreviations: 2q4, 2 mg every 4 weeks; BCVA, best-corrected visual acuity; CST, central subfield thickness; IAI, intravitreal aflibercept injection; r, correlation; R2, coefficient of determination.